Breaking News Instant updates and real-time market news.

2022-12-01 06:06:05 SWTX SpringsWorks Therapeutics $24.16 / +0.72 (+3.07%) 06:06 12/01/22 12/01 06:06 12/01/22 06:06	SpringsWorks Therapeutics initiated with a Buy at BofA BofA analyst Alec Stranahan initiated coverage of SpringsWorks Therapeutics with a Buy rating and $45 price target.

2022-12-01 06:06:05

SWTX

SpringsWorks Therapeutics

$24.16 / +0.72 (+3.07%)

06:06

12/01/22

12/01

06:06

12/01/22

06:06

SpringsWorks Therapeutics initiated with a Buy at BofA

BofA analyst Alec Stranahan initiated coverage of SpringsWorks Therapeutics with a Buy rating and $45 price target.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	United Health Products reports anomalies from lab testing of HemoStyp samples » 08:50 03/29/23 03/29 08:50 03/29/23 08:50 UEEC United Health Products / + United Health Products… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News UEEC United Health Products / + 01/31/23 UHP provides update on FDA PMA application, White Lion agreement 12/19/22 United Health Products provides update on PMA application 11/28/22 United Health to submit full PMA application following sample analysis review 10/31/22 United Health Products provides update on PMA application
Initiation	Abbott assumed with a Buy at UBS » 08:49 03/29/23 03/29 08:49 03/29/23 08:49 ABT Abbott $97.10 / -1.345 (-1.37%) UBS analyst Danielle… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ABT Abbott $97.10 / -1.345 (-1.37%) 03/07/23 Abbott: FDA clears first first commercially available TBI blood test 03/06/23 DexCom down more than 7% after FDA gives nod to Abbott CGM sensors 03/06/23 Abbott: FDA clears FreeStyle Libre 2, FreeStyle Libre 3 sensors 03/05/23 Abbott announces late-breaking data from landmark COAPT trial ABT Abbott $97.10 / -1.345 (-1.37%) 03/28/23 UBS Abbott initiated with a Buy at UBS 03/08/23 Jefferies DexCom pullback on Abbott news a buying opportunity, says Jefferies 03/08/23 Wells Fargo Wells downgrades Edwards Lifesciences with Medtronic gaining share 03/07/23 BofA BofA says buy DexCom on weakness after Abbott's Libre gets pump integration ABT Abbott $97.10 / -1.345 (-1.37%) 01/25/23 Abbott sees FY23 adjusted EPS $4.30-$4.50, consensus $4.40 01/25/23 Abbott reports Q4 adjusted EPS $1.03, consensus 92c 01/24/23 Notable companies reporting before tomorrow's open 01/24/23 Notable companies reporting before tomorrow's open ABT Abbott $97.10 / -1.345 (-1.37%) 01/22/23 Abbott says cooperating with DoJ in baby formula probe, Bloomberg says 01/20/23 DOJ investigating conduct at Abbott infant-formula plant, WSJ reports ABT Abbott $97.10 / -1.345 (-1.37%) 02/22/23 Diabetes management stocks slide on report of tech giant's breakthroughs 02/13/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/09/23 What You Missed On Wall Street On Thursday 02/09/23 What You Missed On Wall Street This Morning 04/28/23 Abbott Laboratories ABT Abbott $97.10 / -1.345 (-1.37%) 11/28/22 Abbott put volume heavy and directionally bearish 10/07/22 Early notable gainers among liquid option names on October 7th 10/06/22 Abbott call volume above normal and directionally bullish
Hot Stocks	Ionis Pharmaceuticals' IONIS-MAPTRx shows tau reduction efficacy in Alzheimer's » 08:49 03/29/23 03/29 08:49 03/29/23 08:49 IONS Ionis Pharmaceuticals $34.30 / +0.575 (+1.71%) , BIIB Biogen $270.29 / +0.66 (+0.24%) Ionis Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options IONS BIIB IONS Ionis Pharmaceuticals $34.30 / +0.575 (+1.71%) 03/27/23 Ionis Pharmaceuticals announces NEURO-TTRansform study met co-primary endpoints 03/23/23 Ionis says FDA advisors vote in favor of potential tofersen accelerated approval 03/07/23 Ionis Pharmaceuticals: FDA accepts NDA for eplontersen 02/01/23 Ionis Pharmaceuticals: GSK advances bepirovirsen into Phase 3 development BIIB Biogen $270.29 / +0.66 (+0.24%) 03/22/23 Biogen provides update on AdCom meeting on Tofersen for SOD1-ALS 03/22/23 Inozyme appoints Matthew Winton as COO 03/20/23 FDA posts briefing document for advisors' review of Biogen's ALS drug 03/16/23 Biogen receives favorable court ruling on TECFIDERA IONS BIIB IONS Ionis Pharmaceuticals $34.30 / +0.575 (+1.71%) 03/21/23 Bernstein Ionis Pharmaceuticals initiated with an Underperform at Bernstein 02/23/23 SVB Securities Ionis Pharmaceuticals price target lowered to $27 from $34 at SVB Securities 02/23/23 Barclays Ionis Pharmaceuticals price target lowered to $40 from $44 at Barclays 01/19/23 Piper Sandler Ionis Pharmaceuticals price target raised to $62 from $60 at Piper Sandler BIIB Biogen $270.29 / +0.66 (+0.24%) 03/21/23 BofA FDA briefing docs suggest FDA in favor of Biogen's tofersen, says BofA 03/17/23 Stifel Stifel trims Biogen target, but has more confidence lecanemab 'best-in-class' 03/13/23 RBC Capital Biogen price target raised to $350 from $335 at RBC Capital 03/09/23 BofA No ad com suggests positive potential outcome for Sage's zura, says BofA IONS BIIB IONS Ionis Pharmaceuticals $34.30 / +0.575 (+1.71%) 02/22/23 Ionis Pharmaceuticals sees FY23 revenue $575M, consensus $672.18M 02/22/23 Ionis Pharmaceuticals reports Q4 EPS (37c), consensus (92c) 11/09/22 Ionis Pharmaceuticals backs 2022 revenue above $575M, consensus $594.45M 11/09/22 Ionis Pharmaceuticals reports Q3 EPS (33c), consensus (74c) BIIB Biogen $270.29 / +0.66 (+0.24%) 02/15/23 Biogen sees FY23 EPS $15.00-$16.00, consensus $15.72 02/15/23 Biogen reports Q4 EPS $4.05, consensus $3.48 02/14/23 Notable companies reporting before tomorrow's open 02/14/23 Notable companies reporting before tomorrow's open BIIB BIIB Biogen $270.29 / +0.66 (+0.24%) 03/13/23 VA to widely cover new Alzheimer's treatment from Eisai and Biogen, STAT says 01/11/23 FDA Commissioner defends FDA's approval of Biogen's Aduhelm, WSJ reports 12/23/22 Third trial death tied to Biogen and Eisai Alzheimer's drug, Science reports 11/28/22 Second death linked to Eisai's lecanemab Alzheimer's drug, Science says IONS BIIB IONS Ionis Pharmaceuticals $34.30 / +0.575 (+1.71%) 03/24/23 Buy/Sell: Wall Street's top 10 stock calls this week 03/21/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations BIIB Biogen $270.29 / +0.66 (+0.24%) 02/15/23 What You Missed On Wall Street On Wednesday 02/15/23 What You Missed On Wall Street This Morning 02/15/23 Fly Intel: Pre-market Movers 01/20/23 Fly Intel: Pre-market Movers 07/06/23 PDUFA Date for Leqembi 08/05/23 PDUFA Date for Zuranolone 12/22/23 PDUFA Date for Eplontersen 05/04/23 Biogen BIIB BIIB Biogen $270.29 / +0.66 (+0.24%) 11/30/22 Early notable gainers among liquid option names on November 30th 11/14/22 Early notable gainers among liquid option names on November 14th 10/13/22 Early notable gainers among liquid option names on October 13th 09/29/22 Unusually active option classes on open September 29th
Recommendations	VF Corp. price target lowered to $24 from $28 at UBS » 08:48 03/29/23 03/29 08:48 03/29/23 08:48 VFC VF Corp. $21.21 / +0.375 (+1.80%) UBS analyst Jay Sole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options VFC VF Corp. $21.21 / +0.375 (+1.80%) 02/07/23 VF Corp. expects Vans to be down high single digit percentage range in FY23 02/07/23 VF Corp. sees $225M of annualized savings in fiscal 2024 02/07/23 VF commencing strategic alternatives for Global Packs business 02/07/23 VF Corp. cuts quarterly dividend to 30c from 51c per share VFC VF Corp. $21.21 / +0.375 (+1.80%) 03/20/23 Williams Trading VF Corp. double upgraded to Buy at Williams Trading after management meetings 03/20/23 Baird VF Corp. price target lowered to $24 from $30 at Baird 03/20/23 Williams Trading VF Corp. upgraded to Buy from Sell at Williams Trading 02/10/23 Stifel VF Corp. upgraded to Buy from Hold at Stifel VFC VF Corp. $21.21 / +0.375 (+1.80%) 02/07/23 VF Corp. sees FY24 operating earnings up double-digits 02/07/23 VF Corp. sees FY23 adjusted EPS $2.05-$2.15 vs. prior $2.00-$2.20 02/07/23 VF Corp. reports Q3 adjusted EPS $1.12, consensus 98c 02/07/23 Notable companies reporting after market close VFC VF Corp. $21.21 / +0.375 (+1.80%) 03/20/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/10/23 What You Missed On Wall Street On Friday 02/10/23 What You Missed On Wall Street This Morning 02/10/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations VFC VF Corp. $21.21 / +0.375 (+1.80%) 03/15/23 V F Corp call volume above normal and directionally bullish 03/10/23 V F Corp call volume above normal and directionally bullish 03/01/23 V F Corp call volume above normal and directionally bullish 02/09/23 V F Corp put volume heavy and directionally bearish
Hot Stocks	Conduent implements child support payment processing system in New Hampshire » 08:48 03/29/23 03/29 08:48 03/29/23 08:48 CNDT Conduent $3.15 / -0.02 (-0.63%) Conduent announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CNDT Conduent $3.15 / -0.02 (-0.63%) 03/06/23 Conduent to showcase fare collection solutions at Transport Ticketing Global 02/23/23 Conduent selected by Virgin Atlantic to support customer experience 02/14/23 Conduent selected by NMHSD to deliver Medicaid Management Information System 02/07/23 Conduent, Genesys partner to enhance customer experience solution CNDT Conduent $3.15 / -0.02 (-0.63%) 05/31/22 Gordon Haskett Conduent 'overdue to be sold,' says Gordon Haskett CNDT Conduent $3.15 / -0.02 (-0.63%) 11/01/22 Conduent sees 2022 revenue $3.85B-$3.95B, consensus $3.91B 11/01/22 Conduent reports Q3 adjusted EPS 9c, consensus 8c
Recommendations	Under Armour price target lowered to $15 from $16 at UBS » 08:48 03/29/23 03/29 08:48 03/29/23 08:48 UAA Under Armour / + , UA Under Armour $8.04 / +0.03 (+0.37%) UBS lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options UAA UA UAA Under Armour / + 02/08/23 Under Armour expects macroeconomic backdrop to remain uneven in 2023 12/21/22 Under Armour names Stephanie Linnartz as CEO 12/21/22 Marriott president Stephanie Linnartz leaving to become CEO of Under Armour 11/18/22 Adtalem Global Education appoints Blake Simpson as CCO UA Under Armour $8.04 / +0.03 (+0.37%) 02/08/23 Under Armour expects macroeconomic backdrop to remain uneven in 2023 12/21/22 Under Armour names Stephanie Linnartz as CEO 12/21/22 Marriott president Stephanie Linnartz leaving to become CEO of Under Armour 11/18/22 Adtalem Global Education appoints Blake Simpson as CCO UAA UA UAA Under Armour / + 03/21/23 Evercore ISI Foot Locker upgraded to Outperform from In Line at Evercore ISI 03/16/23 Williams Trading Under Armour upgraded to Buy from Hold at Williams Trading 03/16/23 Redburn Under Armour initiated with a Buy at Redburn 03/13/23 JPMorgan Under Armour downgraded to Neutral from Overweight at JPMorgan UA Under Armour $8.04 / +0.03 (+0.37%) 03/21/23 Evercore ISI Foot Locker upgraded to Outperform from In Line at Evercore ISI 03/16/23 Williams Trading Under Armour upgraded to Buy from Hold at Williams Trading 03/16/23 Redburn Under Armour initiated with a Buy at Redburn 03/13/23 JPMorgan Under Armour downgraded to Neutral from Overweight at JPMorgan UAA UA UAA Under Armour / + 02/08/23 Under Armour raises FY23 adjusted EPS view to 52c-56c from 44c-48c 02/08/23 Under Armour reports Q3 adjusted EPS 16c, consensus 9c 02/07/23 Notable companies reporting before tomorrow's open 02/07/23 Notable companies reporting before tomorrow's open UA Under Armour $8.04 / +0.03 (+0.37%) 02/08/23 Under Armour raises FY23 adjusted EPS view to 52c-56c from 44c-48c 02/08/23 Under Armour reports Q3 adjusted EPS 16c, consensus 9c 02/07/23 Notable companies reporting before tomorrow's open 02/07/23 Notable companies reporting before tomorrow's open UAA UA UAA Under Armour / + 03/24/23 Buy/Sell: Wall Street's top 10 stock calls this week 03/16/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/13/23 What You Missed On Wall Street On Monday 03/13/23 What You Missed On Wall Street This Morning UA Under Armour $8.04 / +0.03 (+0.37%) 03/24/23 Buy/Sell: Wall Street's top 10 stock calls this week 03/16/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/13/23 What You Missed On Wall Street On Monday 03/13/23 What You Missed On Wall Street This Morning 05/19/23 Under Armour UAA UAA Under Armour / + 10/31/22 Under Armour Class A call volume above normal and directionally bullish 10/10/22 Under Armour Class A call volume above normal and directionally bullish
Initiation	Intuitive Surgical assumed with a Neutral at UBS » 08:48 03/29/23 03/29 08:48 03/29/23 08:48 ISRG Intuitive Surgical $249.55 / -2.74 (-1.09%) UBS analyst Danielle… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options ISRG Intuitive Surgical $249.55 / -2.74 (-1.09%) 01/24/23 Intuitive Surgical sees FY23 procedure growth up 12%-16% 10/25/22 Intuitive Surgical reports $1B accelerated share repurchase agreement 10/19/22 Intuitive Surgical receives Royal College of Surgeons of England accreditation 10/18/22 Intuitive Surgical raises FY22 procedure growth view to 17%-18% from 14%-16.5% ISRG Intuitive Surgical $249.55 / -2.74 (-1.09%) 03/28/23 UBS Intuitive Surgical initiated with a Neutral at UBS 03/24/23 Evercore ISI Evercore says Intuitive Surgical outperformance tied to new system speculation 03/23/23 William Blair William Blair starts Intuitive Surgical at Outperform on favorable risk/reward 03/23/23 William Blair Intuitive Surgical initiated with an Outperform at William Blair ISRG Intuitive Surgical $249.55 / -2.74 (-1.09%) 01/24/23 Intuitive Surgical reports Q4 EPS $1.23, consensus $1.25 01/24/23 Notable companies reporting after market close 01/11/23 Intuitive Surgical sees Q4 revenue $1.66B, consensus $1.68B 10/18/22 Intuitive Surgical reports Q3 EPS $1.19, consensus $1.12 ISRG Intuitive Surgical $249.55 / -2.74 (-1.09%) 03/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/25/23 What You Missed On Wall Street On Wednesday 01/25/23 What You Missed On Wall Street This Morning 01/25/23 Fly Intel: Pre-market Movers 04/18/23 Intuitive Surgical - ISRG 04/27/23 Intuitive Surgical Inc ISRG Intuitive Surgical $249.55 / -2.74 (-1.09%) 03/24/23 Early notable gainers among liquid option names on March 24th 01/24/23 Intuitive Surgical options imply 4.8% move in share price post-earnings 10/19/22 Early notable gainers among liquid option names on October 19th 10/18/22 Intuitive Surgical options imply 6.0% move in share price post-earnings
Recommendations	Tapestry price target lowered to $42 from $44 at UBS » 08:48 03/29/23 03/29 08:48 03/29/23 08:48 TPR Tapestry $41.73 / +0.99 (+2.43%) UBS analyst Jay Sole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TPR Tapestry $41.73 / +0.99 (+2.43%) 12/04/22 Fly Intel: Top five weekend stock stories TPR Tapestry $41.73 / +0.99 (+2.43%) 02/10/23 Morgan Stanley Tapestry assumed with an Equal Weight at Morgan Stanley 02/10/23 Baird Tapestry price target raised to $52 from $45 at Baird 01/23/23 Barclays Capri Holdings price target raised to $72 from $56 at Barclays 01/23/23 Barclays Tapestry downgraded to Equal Weight from Overweight at Barclays TPR Tapestry $41.73 / +0.99 (+2.43%) 02/09/23 Tapestry raises FY23 EPS view to $3.70-$3.75 from $3.60-$3.70, consensus $3.65 02/09/23 Tapestry reports Q2 EPS $1.36, consensus $1.27 02/08/23 Notable companies reporting before tomorrow's open 02/08/23 Notable companies reporting before tomorrow's open TPR Tapestry $41.73 / +0.99 (+2.43%) 12/03/22 Tapestry, Saia among small-cap stocks set for big gains, Barron's says TPR Tapestry $41.73 / +0.99 (+2.43%) 02/09/23 What You Missed On Wall Street On Thursday 02/09/23 What You Missed On Wall Street This Morning 02/09/23 Fly Intel: Pre-market Movers 01/23/23 What You Missed On Wall Street On Monday TPR Tapestry $41.73 / +0.99 (+2.43%) 03/09/23 Tapestry put volume heavy and directionally bearish 11/04/22 Unusually active option classes on open November 4th
Recommendations	Skechers price target lowered to $60 from $69 at UBS » 08:47 03/29/23 03/29 08:47 03/29/23 08:47 SKX Skechers $45.78 / +1.155 (+2.59%) UBS lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options SKX Skechers $45.78 / +1.155 (+2.59%) 03/08/23 Skechers and Martha Stewart team on First footwear collaboration 10/26/22 Skechers issues statement on unauthorized visit by Kanye West 10/26/22 Skechers falls -8.9% 10/25/22 Skechers falls 11% to $32.00 after Q4 guidance misses estimates SKX Skechers $45.78 / +1.155 (+2.59%) 02/03/23 UBS Skechers price target raised to $69 from $63 at UBS 02/03/23 Cowen Skechers price target lowered to $62 from $65 at Cowen 01/23/23 Cowen Skechers upgraded to Outperform at Cowen on momentum and margin recovery 01/23/23 Deutsche Bank Skechers price target raised to $54 from $43 at Deutsche Bank SKX Skechers $45.78 / +1.155 (+2.59%) 02/02/23 Skechers sees FY23 EPS $2.80-$3.00, consensus $3.04 02/02/23 Skechers sees Q1 EPS 55c-60c, consensus 84c 02/02/23 Skechers reports Q4 adjusted EPS 48c, consensus 36c 02/02/23 Notable companies reporting after market close SKX Skechers $45.78 / +1.155 (+2.59%) 02/02/23 Fly Intel: After-Hours Movers 01/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/18/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/29/22 What You Missed On Wall Street On Thursday SKX Skechers $45.78 / +1.155 (+2.59%) 10/26/22 Largest borrow rate increases among liquid names 10/25/22 Skechers options imply 9.4% move in share price post-earnings
Recommendations	Ralph Lauren price target lowered to $154 from $157 at UBS » 08:47 03/29/23 03/29 08:47 03/29/23 08:47 RL Ralph Lauren $115.54 / +2.77 (+2.46%) UBS analyst Jay Sole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options RL Ralph Lauren $115.54 / +2.77 (+2.46%) 02/09/23 Ralph Lauren CEO: Macro environment 'choppy,' consumer 'resilient' 01/25/23 Ralph Lauren CEO sells $2.31M in common stock 01/19/23 Ralph Lauren CEO sells $2.22M in common stock 11/10/22 Ralph Lauren sees gross margin expansion in 2H RL Ralph Lauren $115.54 / +2.77 (+2.46%) 02/13/23 BofA Ralph Lauren upgraded to Buy from Neutral at BofA 02/10/23 Deutsche Bank Ralph Lauren price target raised to $119 from $114 at Deutsche Bank 02/10/23 Cowen Ralph Lauren price target raised to $151 from $148 at Cowen 02/10/23 Credit Suisse Ralph Lauren price target raised to $135 from $115 at Credit Suisse RL Ralph Lauren $115.54 / +2.77 (+2.46%) 02/09/23 Ralph Lauren backs FY23 revenue view up 13.5%-14%, consensus $6.28B 02/09/23 Ralph Lauren sees Q4 revenue up mid- to high-single digits, consensus $1.45B 02/09/23 Ralph Lauren reports Q3 EPS $3.20, consensus $2.92 02/08/23 Notable companies reporting before tomorrow's open RL Ralph Lauren $115.54 / +2.77 (+2.46%) 02/18/23 Buy/Sell: Wall Street's top 10 stock calls this week 02/13/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/09/23 Fly Intel: Pre-market Movers 01/27/23 What You Missed On Wall Street On Friday RL Ralph Lauren $115.54 / +2.77 (+2.46%) 03/28/23 Early notable gainers among liquid option names on March 28th 11/11/22 Early notable gainers among liquid option names on November 11th

Recommendations	Children's Place price target lowered to $40 from $45 at UBS » 08:47 03/29/23 03/29 08:47 03/29/23 08:47 PLCE Children's Place $38.28 / +0.25 (+0.66%) UBS analyst Jay Sole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly PLCE Children's Place $38.28 / +0.25 (+0.66%) 02/06/23 Children's Place falls 10% to $42.08 after lowering Q4 outlook 11/17/22 Children's Place expects to close 40-50 stores this year 10/24/22 Children's Place appoints Sheamus Toal as CFO 10/17/22 Ollie's Bargain Outlet appoints Rob Helm as CFO PLCE Children's Place $38.28 / +0.25 (+0.66%) 02/07/23 Telsey Advisory Children's Place downgraded to Market Perform from Outperform at Telsey 11/18/22 UBS Children's Place price target lowered to $41 from $43 at UBS 08/18/22 B. Riley Children's Place price target lowered to $64 from $69 at B. Riley 08/16/22 B. Riley Children's Place price target lowered to $69 from $84 at B. Riley PLCE Children's Place $38.28 / +0.25 (+0.66%) 03/16/23 Children's Place sees FY23 adjusted EPS $2.50-$3.00, consensus $3.35 03/16/23 Children's Place sees Q1 adjusted EPS ($1.60)-($1.90), consensus ($1.21) 03/16/23 Children's Place reports Q4 EPS ($4.10), consensus ($4.09) 02/06/23 Children's Place lowers Q4 adjusted EPS view to ($4.02)-($4.41) from 50c-75c PLCE Children's Place $38.28 / +0.25 (+0.66%) 03/16/23 What You Missed On Wall Street On Thursday 03/16/23 What You Missed On Wall Street This Morning 02/06/23 What You Missed On Wall Street On Monday 02/06/23 What You Missed On Wall Street This Morning
Initiation	Medtronic assumed with a Sell at UBS » 08:47 03/29/23 03/29 08:47 03/29/23 08:47 MDT Medtronic / + UBS assumed coverage of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MDT Medtronic / + 03/21/23 Medtronic, Nvidia collaborate to build AI platform for medical devices 03/15/23 Medtronic receives CE Mark for the Affera Mapping and Ablation System 03/06/23 Medtronic's PulseSelect PFA System exceeds safety performance goal in trial 02/24/23 Medtronic announces one-year data from ADAPT study of MiniMed 780G system MDT Medtronic / + 03/28/23 UBS Medtronic assumed at Sell from Buy at UBS 03/28/23 UBS Medtronic downgraded to Sell from Buy at UBS 03/08/23 Wells Fargo Wells downgrades Edwards Lifesciences with Medtronic gaining share 02/22/23 Deutsche Bank Medtronic price target raised to $87 from $80 at Deutsche Bank MDT Medtronic / + 02/21/23 Medtronic sees Q4 EPS $1.55-$1.57, consensus $1.58 02/21/23 Medtronic narrows FY23 EPS view to $5.28-$5.30 from $5.25-$5.30 02/21/23 Medtronic reports Q3 EPS $1.30, consensus $1.27 11/22/22 Medtronic sees Q3 adjusted EPS $1.25-$1.27, consensus $1.40 MDT Medtronic / + 02/22/23 Apple hits breakthroughs in glucose monitoring project, Bloomberg reports 02/08/23 Apple names Medtronic's Surface as Chief People Officer, Bloomberg says 12/17/22 Amazon, Google among Barron's 10 favorite stocks for 2023 12/15/22 GE among companies studying Medtronic businesses, Bloomberg reports MDT Medtronic / + 03/08/23 What You Missed On Wall Street On Wednesday 03/08/23 What You Missed On Wall Street This Morning 02/22/23 Diabetes management stocks slide on report of tech giant's breakthroughs 02/21/23 What You Missed On Wall Street On Tuesday MDT Medtronic / + 02/09/23 Medtronic put volume heavy and directionally bearish 01/09/23 Medtronic put volume heavy and directionally bearish 11/21/22 Early notable gainers among liquid option names on November 21st 11/04/22 Medtronic call volume above normal and directionally bullish
Recommendations	Kontoor Brands price target lowered to $65 from $66 at UBS » 08:47 03/29/23 03/29 08:47 03/29/23 08:47 KTB Kontoor Brands $47.88 / +0.7 (+1.48%) UBS analyst Jay Sole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events KTB Kontoor Brands $47.88 / +0.7 (+1.48%) 02/28/23 Kontoor Brands rises 14.8% 02/28/23 Kontoor Brands rises 12.6% 10/24/22 Kontoor Brands raises quarterly dividend by 4% to 48c per share 10/03/22 Kontoor Brands names Ezio Garciamendez as Chief Supply Chain Officer KTB Kontoor Brands $47.88 / +0.7 (+1.48%) 03/08/23 UBS Kontoor Brands price target raised to $66 from $54 at UBS 03/07/23 Barclays Kontoor Brands price target raised to $51 from $37 at Barclays 03/01/23 Wells Fargo Kontoor Brands price target raised to $59 from $48 at Wells Fargo 02/28/23 Stifel Kontoor Brands upgraded to Buy at Stifel amid brand momentum, share gains KTB Kontoor Brands $47.88 / +0.7 (+1.48%) 02/28/23 Kontoor Brands sees FY23 EPS $4.55-$4.75, consensus $4.36 02/28/23 Kontoor Brands reports Q4 adjusted EPS 88c, consensus 67c 11/03/22 Kontoor Brands cuts FY22 adjusted EPS view to $4.35-$4.40 from $4.40-$4.50 11/03/22 Kontoor Brands reports Q3 adjusted EPS $1.11, consensus 88c KTB Kontoor Brands $47.88 / +0.7 (+1.48%) 02/28/23 What You Missed On Wall Street On Tuesday 02/28/23 What You Missed On Wall Street This Morning 04/20/23 Kontoor Brands, Inc.
Recommendations	nCino price target lowered to $33 from $35 at Needham » 08:46 03/29/23 03/29 08:46 03/29/23 08:46 NCNO nCino $22.35 / -0.01 (-0.04%) Needham analyst Mayank… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options NCNO nCino $22.35 / -0.01 (-0.04%) 02/28/23 nCino selected by JFG to modernize multiple lines of business 02/22/23 nCino's SimpleNexus announces Avidia Bank implemented Nexus Closing 02/13/23 nCino says DOJ investigation closed, no fines or penalties imposed 02/07/23 nCino expands nCino IQ offerings through partnership with rich data company NCNO nCino $22.35 / -0.01 (-0.04%) 07:46 Today Truist nCino price target lowered to $40 from $45 at Truist 07:30 Today BofA nCino price target lowered to $30 from $32 at BofA 05:29 Today Barclays nCino price target lowered to $26 from $35 at Barclays 03/24/23 Morgan Stanley nCino price target lowered to $27 from $35 at Morgan Stanley NCNO nCino $22.35 / -0.01 (-0.04%) 03/28/23 nCino reports Q4 EPS 4c, consensus (5c) 01/19/23 nCino backs FY23 EPS view of (15c)-(17c), consensus (16c) 01/19/23 nCino backs Q4 EPS view of (4c)-(5c), consensus (5c) 11/30/22 nCino raises FY23 EPS view to (17c)-(15c) from (19c)-(17c), consensus (17c) NCNO nCino $22.35 / -0.01 (-0.04%) 03/28/23 Fly Intel: After-Hours Movers 03/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/14/23 What You Missed On Wall Street On Tuesday 03/14/23 What You Missed On Wall Street This Morning NCNO nCino $22.35 / -0.01 (-0.04%) 11/30/22 nCino options imply 9.0% move in share price post-earnings
Recommendations	Kohl's price target lowered to $16 from $18 at UBS » 08:46 03/29/23 03/29 08:46 03/29/23 08:46 KSS Kohl's $21.77 / +0.09 (+0.42%) UBS lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KSS Kohl's $21.77 / +0.09 (+0.42%) 03/22/23 Kohl's announces locations of 250 new Sephora at Kohl's opening this year 02/28/23 Kohl's appoints Dave Alves COO 02/09/23 Kohl's names Nick Jones Chief Merchandising and Digital Officer 02/02/23 Kohl's names Tom Kingsbury as CEO KSS Kohl's $21.77 / +0.09 (+0.42%) 03/02/23 Deutsche Bank Kohl's price target lowered to $31 from $34 at Deutsche Bank 03/02/23 Citi Kohl's price target lowered to $26 from $29 at Citi 03/02/23 Morgan Stanley Kohl's assumed with an Underweight at Morgan Stanley 03/01/23 Credit Suisse Credit Suisse lowers Kohl's price target to $27 following quarterly results KSS Kohl's $21.77 / +0.09 (+0.42%) 03/01/23 Kohl's sees FY23 EPS $2.10-$2.70, consensus $2.99 03/01/23 Kohl's reports Q4 adjusted EPS ($2.49), consensus 98c 02/28/23 Notable companies reporting before tomorrow's open 02/28/23 Notable companies reporting before tomorrow's open KSS Kohl's $21.77 / +0.09 (+0.42%) 01/25/23 Interim Kohl's CEO Kingsbury in late-stage talks to be permanent CEO, NYT says 01/10/23 Franchise Group could go private or may bid to buy Conn's, WSJ reports 10/12/22 Macellum urges Kohl's to make board changes, WSJ reports KSS Kohl's $21.77 / +0.09 (+0.42%) 03/01/23 What You Missed On Wall Street On Wednesday 03/01/23 What You Missed On Wall Street This Morning 03/01/23 Fly Intel: Pre-market Movers 01/30/23 What You Missed On Wall Street On Monday 05/10/23 Kohl's Corporation KSS Kohl's $21.77 / +0.09 (+0.42%) 03/10/23 Kohl's call volume above normal and directionally bullish 03/01/23 Unusually active option classes on open March 1st 01/30/23 Kohl's put volume heavy and directionally bearish 01/27/23 Unusually active option classes on open January 27th
Earnings	Cintas reports Q3 EPS $3.14, consensus $3.04 » 08:46 03/29/23 03/29 08:46 03/29/23 08:46 CTAS Cintas $443.89 / +3.48 (+0.79%) Reports Q3 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CTAS Cintas $443.89 / +3.48 (+0.79%) 12/16/22 Cintas launches electric vehicle pilot program 11/15/22 Cintas expands cleanroom footprint with new facility in New York CTAS Cintas $443.89 / +3.48 (+0.79%) 12/22/22 Wells Fargo Cintas price target raised to $450 from $393 at Wells Fargo 12/22/22 Deutsche Bank Cintas price target raised to $507 from $490 at Deutsche Bank 12/22/22 Baird Cintas price target raised to $500 from $475 at Baird 12/22/22 Morgan Stanley Cintas price target raised to $401 from $373 at Morgan Stanley CTAS Cintas $443.89 / +3.48 (+0.79%) 08:41 Today Cintas raises FY23 EPS view to $12.70-$12.90 from $12.50-$12.80 08:37 Today Cintas reports Q4 EPS $3.14, consensus $3.04 12/21/22 Cintas raises FY23 EPS view to $12.50-$12.80 from $12.30-$12.65 12/21/22 Cintas reports Q2 EPS $3.12, consensus $3.03 CTAS Cintas $443.89 / +3.48 (+0.79%) 12/21/22 What You Missed On Wall Street On Wednesday 12/21/22 What You Missed On Wall Street This Morning 10:00 Today Cintas - CTAS
Recommendations	Hanesbrands price target lowered to $5 from $7 at UBS » 08:46 03/29/23 03/29 08:46 03/29/23 08:46 HBI Hanesbrands $5.11 / +0.1 (+2.00%) UBS analyst Jay Sole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options HBI Hanesbrands $5.11 / +0.1 (+2.00%) 03/20/23 S&P announces changes to S&P 400, 600 indices at open on 3/20 03/07/23 Hanesbrands and UCLA announce multi-year apparel agreement, no terms 03/03/23 S&P announces changes to S&P 400, 600 indices at open on 3/20 02/02/23 Hanesbrands falls -22.6% HBI Hanesbrands $5.11 / +0.1 (+2.00%) 02/03/23 Citi Hanesbrands price target lowered to $7 from $8 at Citi 01/13/23 Barclays Hanesbrands price target raised to $8 from $7 at Barclays 11/09/22 Credit Suisse Hanesbrands downgraded to Neutral from Outperform at Credit Suisse 11/06/22 Citi Hanesbrands price target lowered to $7 from $11 at Citi HBI Hanesbrands $5.11 / +0.1 (+2.00%) 02/02/23 Hanesbrands sees FY23 EPS 31c-42c, consensus 94c 02/02/23 Hanesbrands sees Q1 EPS (4c)- (9c) , consensus 14c 02/02/23 Hanesbrands reports Q4 EPS 7c, consensus 7c 01/12/23 Hanesbrands sees Q4 sales 'slightly above' top end of outlook range HBI Hanesbrands $5.11 / +0.1 (+2.00%) 02/02/23 What You Missed On Wall Street On Thursday 02/02/23 What You Missed On Wall Street This Morning 01/13/23 What You Missed On Wall Street On Friday 01/13/23 What You Missed On Wall Street This Morning 04/24/23 Hanesbrands Inc. HBI Hanesbrands $5.11 / +0.1 (+2.00%) 02/24/23 HanesBrands call volume above normal and directionally bullish 02/22/23 HanesBrands put volume heavy and directionally bearish 02/03/23 HanesBrands call volume above normal and directionally bullish 01/24/23 HanesBrands put volume heavy and directionally bearish
Recommendations	Canada Goose price target lowered to $20 from $23 at UBS » 08:46 03/29/23 03/29 08:46 03/29/23 08:46 GOOS Canada Goose $18.02 / -0.005 (-0.03%) UBS analyst Jay Sole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options GOOS Canada Goose $18.02 / -0.005 (-0.03%) 02/02/23 Canada Goose falls -20.7% 11/18/22 Canada Goose launches share repurchase program 11/08/22 Canada Goose appoints Jess Johannson as chief human resources officer GOOS Canada Goose $18.02 / -0.005 (-0.03%) 02/17/23 Evercore ISI Canada Goose downgraded to In Line from Outperform at Evercore ISI 02/08/23 Credit Suisse Canada Goose price target raised to C$36 from C$30 at Credit Suisse 02/06/23 Barclays Canada Goose price target raised to $21 from $20 at Barclays 02/03/23 Cowen Canada Goose price target lowered to $22 from $26 at Cowen GOOS Canada Goose $18.02 / -0.005 (-0.03%) 02/07/23 Canada Goose sees FY23 revenue C$1.18B-C$1.20B, consensus $889.94M 02/07/23 Canada Goose sees FY28 revenue C$3.0B 02/02/23 Canada Goose cuts FY23 adjusted EPS view to C$0.92-C$1.03 from C$1.31-C$1.62 02/02/23 Canada Goose sees Q4 adjusted EPS C$0.00-C$0.12 GOOS Canada Goose $18.02 / -0.005 (-0.03%) 02/17/23 What You Missed On Wall Street On Friday 02/17/23 What You Missed On Wall Street This Morning 02/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/02/23 What You Missed On Wall Street On Thursday GOOS Canada Goose $18.02 / -0.005 (-0.03%) 03/27/23 Largest borrow rate increases among liquid names 02/01/23 Canada Goose put volume heavy and directionally bearish 01/26/23 Canada Goose put volume heavy and directionally bearish 01/11/23 Canada Goose put volume heavy and directionally bearish
Recommendations	Designer Brands price target lowered to $10 from $11 at UBS » 08:45 03/29/23 03/29 08:45 03/29/23 08:45 DBI Designer Brands $8.74 / +0.085 (+0.98%) UBS lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly DBI Designer Brands $8.74 / +0.085 (+0.98%) 03/16/23 Designer Brands rises 11.0% 03/16/23 Designer Brands rises 7.9% 02/08/23 Wolverine sells Keds brand to Designer Brands, no terms given 01/05/23 Designer Brands appoints Doug Howe to succeed CEO effective April 1 DBI Designer Brands $8.74 / +0.085 (+0.98%) 12/02/22 Deutsche Bank Designer Brands price target lowered to $16 from $20 at Deutsche Bank 09/01/22 Deutsche Bank Designer Brands price target raised to $20 from $19 at Deutsche Bank 07/15/22 UBS Designer Brands price target lowered to $14 from $17 at UBS 06/03/22 Deutsche Bank Designer Brands price target raised to $22 from $20 at Deutsche Bank DBI Designer Brands $8.74 / +0.085 (+0.98%) 03/16/23 Designer Brands sees FY23 EPS $1.65-$1.75, consensus $1.77 03/16/23 Designer Brands reports Q4 adjusted EPS 7c, consensus (2c) 01/05/23 Designer Brands still sees FY22 EPS $1.75-$1.80, consensus $1.77 12/01/22 Designer Brands cuts FY22 EPS view to $1.75-$1.80 from $2.05-$2.15 DBI Designer Brands $8.74 / +0.085 (+0.98%) 03/16/23 What You Missed On Wall Street This Morning 03/16/23 Fly Intel: Pre-market Movers 12/01/22 What You Missed On Wall Street On Thursday 12/01/22 What You Missed On Wall Street This Morning
Initiation	Edwards Lifesciences initiated with a Neutral at UBS » 08:45 03/29/23 03/29 08:45 03/29/23 08:45 EW Edwards Lifesciences / + UBS analyst Danielle… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options EW Edwards Lifesciences / + 12/08/22 Edwards Lifesciences CEO Michael Mussallem to retire, Bernard Zovighian succeeds 11/01/22 Edwards Lifesciences authorizes $750M accelerated share repurchase 10/28/22 Edwards Lifesciences falls -16.6% 10/28/22 Edwards Lifesciences falls -14.3% EW Edwards Lifesciences / + 03/28/23 UBS Edwards Lifesciences initiated with a Neutral at UBS 03/08/23 Wells Fargo Wells downgrades Edwards Lifesciences with Medtronic gaining share 03/08/23 Wells Fargo Edwards Lifesciences downgraded to Equal Weight from Overweight at Wells Fargo 02/06/23 Raymond James Edwards Lifesciences downgraded to Market Perform from Outperform at Raymond James EW Edwards Lifesciences / + 01/31/23 Edwards Lifesciences sees Q1 adjusted EPS 58c-64c, consensus 59c 01/31/23 Edwards Lifesciences backs FY23 adjusted EPS $2.45-$2.60, consensus $2.50 01/31/23 Edwards Lifesciences reports Q4 adjusted EPS 64c, consensus 61c 01/31/23 Notable companies reporting after market close EW Edwards Lifesciences / + 03/08/23 What You Missed On Wall Street On Wednesday 03/08/23 What You Missed On Wall Street This Morning 03/08/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/04/23 Buy/Sell: Wall Street's top 10 stock calls this week EW Edwards Lifesciences / + 02/01/23 Early notable gainers among liquid option names on February 1st 01/31/23 Edwards Lifesciences options imply 5.3% move in share price post-earnings 12/05/22 Edwards Lifesciences call volume above normal and directionally bullish 10/31/22 Early notable gainers among liquid option names on October 31st

Recommendations	Carter's price target lowered to $65 from $74 at UBS » 08:45 03/29/23 03/29 08:45 03/29/23 08:45 CRI Carter's $70.68 / +1.085 (+1.56%) UBS analyst Jay Sole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly CRI Carter's $70.68 / +1.085 (+1.56%) 01/26/23 Wedbush Wedbush downgrades Carter's to Neutral as post-COVID 'baby boom" fizzles out 01/26/23 Wedbush Carter's downgraded to Neutral from Outperform at Wedbush 08/01/22 B. Riley Carter's price target lowered to $99 from $114 at B. Riley 08/01/22 UBS Carter's price target raised to $86 from $72 at UBS CRI Carter's $70.68 / +1.085 (+1.56%) 02/24/23 Carter's sees FY23 adjusted EPS $6.15, consensus $6.45 02/24/23 Carter's sees Q1 adjusted EPS 35c-55c, consensus $1.23 02/24/23 Carter's reports Q4 adjusted EPS $2.29, consensus $1.73 10/28/22 Carter's lowers FY22 adjusted EPS view to $6.05-$6.65 from $7.10-$7.60 CRI Carter's $70.68 / +1.085 (+1.56%) 02/24/23 Fly Intel: Pre-market Movers 01/26/23 What You Missed On Wall Street On Thursday 01/26/23 What You Missed On Wall Street This Morning 01/26/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Recommendations	Capri Holdings price target lowered to $59 from $68 at UBS » 08:45 03/29/23 03/29 08:45 03/29/23 08:45 CPRI Capri Holdings / + UBS lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options CPRI Capri Holdings / + 02/08/23 Capri Holdings falls -27.0% 02/08/23 Capri Holdings falls -23.4% 02/08/23 Capri Holdings falls -21.0% 02/08/23 Capri Holdings falls 19% to $54.00 after Q3 results, FY23 guidance miss ests CPRI Capri Holdings / + 02/13/23 Cowen Capri Holdings downgraded to Market Perform from Outperform at Cowen 02/09/23 BMO Capital Capri Holdings price target lowered to $70 from $74 at BMO Capital 02/09/23 Morgan Stanley Capri Holdings assumed with an Overweight at Morgan Stanley 02/09/23 UBS Capri Holdings price target lowered to $68 from $75 at UBS CPRI Capri Holdings / + 02/08/23 Capri Holdings sees Q4 EPS 90c-95c, consensus $1.39 02/08/23 Capri Holdings sees FY23 adjusted EPS $6.10, consensus $6.87 02/08/23 Capri Holdings reports Q3 adjusted EPS $1.84, consensus $2.22 02/07/23 Notable companies reporting before tomorrow's open CPRI Capri Holdings / + 02/13/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/08/23 What You Missed On Wall Street On Wednesday 02/08/23 What You Missed On Wall Street This Morning 02/08/23 Fly Intel: Pre-market Movers CPRI Capri Holdings / + 03/13/23 Capri Holdings put volume heavy and directionally bearish
Recommendations	Core & Main price target raised to $26 from $24 at RBC Capital » 08:45 03/29/23 03/29 08:45 03/29/23 08:45 CNM Core & Main $22.05 / +0.73 (+3.42%) RBC Capital analyst Mike… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly CNM Core & Main $22.05 / +0.73 (+3.42%) 02/13/23 Core & Main to acquire Landscape & Construction Supplies LLC, terms not stated 12/13/22 Core & Main sees FY22 adjusted EBITDA $910M-$930M 11/07/22 Core & Main to acquire Lanier Municipal Supply Co CNM Core & Main $22.05 / +0.73 (+3.42%) 07:22 Today Baird Core & Main price target raised to $33 from $29 at Baird 02/14/23 Loop Capital Loop Capital starts Core & Main with Buy on balanced end market mix 02/13/23 Loop Capital Core & Main initiated with a Buy at Loop Capital 01/10/23 Deutsche Bank Core & Main price target lowered to $40 from $41 at Deutsche Bank CNM Core & Main $22.05 / +0.73 (+3.42%) 03/28/23 Core & Main sees FY23 revenue $6.455B-$6.875B, consensus $6.34B 03/28/23 Core & Main reports Q4 EPS 31c, consensus 32c 12/13/22 Core & Main reports Q3 EPS 65c, consensus 57c 16 Sep CNM Core & Main $22.05 / +0.73 (+3.42%) 03/28/23 What You Missed On Wall Street On Tuesday 03/28/23 What You Missed On Wall Street This Morning
Recommendations	Columbia Sportswear price target lowered to $92 from $96 at UBS » 08:45 03/29/23 03/29 08:45 03/29/23 08:45 COLM Columbia Sportswear $87.43 / +0.96 (+1.11%) UBS analyst Jay Sole… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings COLM Columbia Sportswear $87.43 / +0.96 (+1.11%) 02/06/23 Columbia Sportswear CEO: There is enormous opportunity in footwear COLM Columbia Sportswear $87.43 / +0.96 (+1.11%) 02/05/23 BofA Columbia Sportswear price target raised to $75 from $65 at BofA 02/03/23 Baird Columbia Sportswear price target raised to $97 from $92 at Baird 01/23/23 UBS Columbia Sportswear price target raised to $92 from $90 at UBS 09/29/22 Citi Citi cuts VF target, says reduced outlook still 'somewhat aggressive' COLM Columbia Sportswear $87.43 / +0.96 (+1.11%) 02/02/23 Columbia Sportswear sees FY23 EPS $5.15-$5.55, consensus $5.59 02/02/23 Columbia Sportswear reports Q4 EPS $2.02, consensus $2.28 10/27/22 Columbia Sportswear backs FY22 EPS view of $5.00-$5.40, consensus $5.16 10/27/22 Columbia Sportswear reports Q3 EPS $1.80, consensus $1.67
Hot Stocks	Clean Harbors: With Organic growth only model sees FY27 adjusted EBITDA $1.4B » 08:45 03/29/23 03/29 08:45 03/29/23 08:45 CLH Clean Harbors $133.00 / +0.67 (+0.51%) Clean Harbors will unveil… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CLH Clean Harbors $133.00 / +0.67 (+0.51%) 03/01/23 Clean Harbors appoints Eric Dugas as EVP and CFO 12/22/22 COO of Clean Harbors Gerstenberg sells over $1.9M in company shares 11/02/22 Clean Harbors appoints COO Eric Gerstenberg, CFO Michael Battles as co-CEOs 11/02/22 Clean Harbors sees FY22 adjusted EBITDA $1.01B-$1.03B CLH Clean Harbors $133.00 / +0.67 (+0.51%) 03/05/23 Raymond James Clean Harbors price target raised to $155 from $150 at Raymond James 03/02/23 BMO Capital Clean Harbors price target raised to $154 from $132 at BMO Capital 03/02/23 Oppenheimer Clean Harbors price target raised to $145 from $135 at Oppenheimer 11/03/22 UBS Clean Harbors downgraded to Neutral from Buy at UBS CLH Clean Harbors $133.00 / +0.67 (+0.51%) 03/01/23 Clean Harbors sees FY23 adjusted EBITDA $1.01B-$1.05B 03/01/23 Clean Harbors reports Q EPS $1.44, consensus $1.36 11/02/22 Clean Harbors reports Q3 adjusted EPS $2.43, consensus $2.11 CLH Clean Harbors $133.00 / +0.67 (+0.51%) 01/03/23 Fly Insider: Terns Pharma, Best Buy among week's notable insider trades 09:00 Today Clean Harbors

Events

Earnings calls, analyst events, roadshows and more

UNF
Today at 09:00

UniFirst - UNF Conference Calls
RDW
Today at 09:00

Redwire - RDW Conference Calls
BOSC
Today at 09:00

BOS Better Online Solutions - BOSC Conference Calls
IBEX
Today at 09:00

Ibex - IBEX Conference Calls
CLH
Today at 09:00

Clean Harbors Firm Sponsored Meetings

Virtual Meeting
PAYX
Today at 09:30

Paychex - PAYX Conference Calls
RMR
Today at 09:30

The RMR Group Inc. Firm Sponsored Meetings
Today at 10:00

Joint Committee Meeting Government Event

Teleconference
Today at 10:00

Pending Home Sales Index M/M: February 2023 Government Event
Today at 10:00

Pending Home Sales Index: February 2023 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	YGF X YGF YanGuFang IPO Managers: EF Hutton Priced at: $4.00 2M Shares ZJYL X ZJYL Jin Medical IPO Managers: Prime Number Priced at: $8.00 1M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	BMEA X BMEA Biomea Fusion Secondary Managers: JPMorgan & Citi, Oppenheimer, Barclays $30.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	SYT X SYT Syla Technologies IPO Managers: Boustead $8.00 1.875M Shares
Fri	No deals

View All Syndicate Announcements »

SpringsWorks Therapeutics initiated with a Buy at BofA

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access